A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity
Manmeet Kaur, Saurav Misra
Topics & Concepts
MedicineLiraglutideGlucagon receptorDiabetes mellitusType 2 diabetesWeight lossPopulationFatty liverObesityType 2 Diabetes MellitusInternal medicineDrug developmentAgonistClinical trialOverweightPharmacologyEndocrinologyDiseaseDrugReceptorInsulinEnvironmental healthGlucagonDiabetes Treatment and ManagementPharmacology and Obesity TreatmentRegulation of Appetite and Obesity